Peloton Therapeutics, Inc. announced the appointment of Alan A. Musso as Chief Financial Officer (CFO), effective September 4, 2018. Mr. Musso brings significant financial expertise and operational leadership to Peloton. As Peloton’s first CFO, Mr. Musso will be responsible for corporate financing activities, investor relations, accounting, human resources, information systems, and operations. He will report to John A. Josey, Ph.D., Peloton’s Chief Executive Officer (CEO). Mr. Musso has 30 years of biotechnology and pharmaceutical industry experience, including capital raising, corporate partnering, finance, strategy, and the financial stewardship of publicly-traded companies. He joins Peloton from Bellicum Pharmaceuticals, Inc., where he served as CFO and Treasurer since November 2014 and successfully raised $300 million via an IPO and follow-on financings. Prior to Bellicum, he was CFO at Targacept where he led its 2006 IPO and multiple public and private financings.